M. Joostens

ICSI and severe male-factor infertility: breaking the sperm tail prior to injection.

J. Gerris, E. van Royen, K. Mangelschots, 1995, Human reproduction.

Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 μg), GnRH agonist (buserelin, 500 μg) and human chorionic gonadotrophin (10 000 IU)

J. Gerris, M. Joostens, E. Royen, 1995 .

Serum hCG decline following salpingotomy or salpingectomy for extrauterine pregnancy.

P. Hellemans, J. Gerris, P. Verdonk, 1994, European journal of obstetrics, gynecology, and reproductive biology.

Preliminary results with the use of the ROM-check immunoassay in the early detection of rupture of the amniotic membranes.

P. Hellemans, J. Gerris, M. Baekelandt, 1992, European journal of obstetrics, gynecology, and reproductive biology.

An unexpected triplet heterotopic pregnancy after replacement of two embryos.

M. Kockx, J. Gerris, P. Verdonk, 1998, Human reproduction.

Clinical and endocrine effects of laser vaporization in patients with polycystic ovarian disease.

J. Gerris, J. Verhelst, C. Mahler, 1993, Gynecological Endocrinology.

Endocrinology: Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome

J. Gerris, M. Joostens, S. Meer, 1993 .

Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome.

J. Gerris, M. Joostens, S. van der Meer, 1993, Human reproduction.